Conolidine’s analgesic consequences stem from its interaction with non-opioid pain pathways. In contrast to opioids, which bind to µ-opioid receptors while in the central anxious program, conolidine modulates alternate molecular targets. A Science Improvements examine found that conolidine interacts Using the atypical chemokine receptor ACKR3/CX… Read More